Lidak, Bristol-Myers deal

LDAKA reacquired the rights from Bristol-Myers to manufacture and sell Lidakol (n-docosanol

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE